CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Controlled Release Drug Delivery Market, By Technology (Wurster Technique, Coacervation, Micro Encapsulation, Transdermal, Targeted Delivery, Others), By Therapeutic Area (Infectious Diseases, Oncology, Cardiology, Neurology, Autoimmune Diseases, Others), By Application (Metered Dose Inhalers, Injectables, Infusion Pumps, Drug Eluting Stents, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In June 2024, researchers at the Indian Institute of Technology (IIT) Bhilai, led by Dr. Sanjib Banerjee, developed a 'smart material' designed to deliver anti-cancer drugs in a controlled manner. The goal is to improve treatment effectiveness, minimize side effects, and support early cancer detection. This innovative material is produced using a straightforward and cost-effective process that is compatible with industry standards.
In May 2024, IFF, a global leader in food, beverage, home, personal care, and health sectors, introduced a new controlled release platform. This platform, branded as "Timing is Everything," enhances pharmaceutical therapies by ensuring precise release of active ingredients, aiming to improve patient adherence and therapeutic outcomes.
In June 2022, researchers at the University of Michigan conducted a study showcasing an innovative approach to microencapsulating drugs, facilitating gradual release of multiple peptide drugs within the body.
In March 2022, Evonik introduced Eudratec SoluFlow, a novel microparticle technology designed to improve the solubility of active pharmaceutical ingredients in oral medications. This advancement addresses the challenge posed by the insolubility of more than 70% of newly developed small molecules, opening avenues for the creation of new oral therapies across diverse fields such as cancer, cardiovascular diseases, infectious diseases, and diabetes.